Latest Listings And Ipos News

Babylon Pump & Power Limited (ASX – BPP) announces transformational acquisitions of Blue Hire and Matrix Hydro Services, significantly expanding its equipment rental and water management capabilities. The company is funding this growth through a $3.5 million entitlement offer and a $21.2 million debt facility, targeting a doubling of EBITDA by FY26.

Loyal Lithium Limited remains suspended from ASX trading after missing its deadline to disclose details of a proposed acquisition and respond to a price query, raising fresh questions about the company’s compliance and strategic direction.

James Hardie Industries is set to terminate its American Depositary Share program following its merger with The AZEK Company and direct NYSE listing, simplifying its share structure for investors.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Vinyl Group Ltd has voluntarily suspended trading on the ASX pending a Federal Court decision on its application for relief after failing to lodge required cleansing notices on time.

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

Hydralyte USA reports its best EBITDA performance since IPO, driven by strong sales and cost reductions, setting the stage for growth with upcoming product launches.

Way2VAT Ltd has successfully raised A$2 million through a discounted share placement, aiming to bolster working capital and reduce short-term debt as it capitalises on recent client wins.

G11 Resources has appointed Martin Donohue as Executive Chairman to fast-track exploration at its Wilandra VMS Copper project while its CEO steps down, signaling a strategic pivot.

EV Resources Limited has agreed to sell its Yanamina Gold and Silver Project in Peru to Daura Gold Corp for US$6 million, a move that will bolster EVR’s cash reserves and sharpen its strategic focus.

BSA Limited announces a significant leadership overhaul and financial restructuring following a failed NBN Co tender, appointing Sasho Kacevski as CEO and Arjan van Ameyde as CFO to steer the company’s next phase.

Radiopharm Theranostics has unveiled encouraging preclinical results for its Lu177-B7H3 monoclonal antibody, RV01, paving the way for a mid-2025 Investigational New Drug submission and a Phase 1 trial later that year.